An interventional study of In-hospital nonculprit-lesions percutaneous coronary intervention (PCI) and After-discharge nonculprit-lesions percutaneous coronary intervention (PCI) in STEMI - ST Elevation Myocardial Infarction and Multivessel Coronary Artery Disease, sponsored by Hospital General Universitario de Valencia. Completed at 1 site in Spain. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-04-24.
Sponsored by Hospital General Universitario de Valencia · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in ST Elevation Myocardial Infarction with a site in Spain — 4 open to participants now, 10 under way, 1 of them phase 3. ST Elevation Myocardial Infarction · Spain.
Among the 41 studies in ST Elevation Myocardial Infarction with a site in Spain, this one is the 19th largest by enrollment of the 27 interventional ones that give a count, is one of 6 that started in 2018, is one of 16 with no phase, and was the 25th registered.
855 studies on the registry are indexed under ST Elevation Myocardial Infarction; 201 are open to participants now.
Browse ST Elevation Myocardial Infarction studies →4 of the 41 studies in ST Elevation Myocardial Infarction with a site in Spain are open now. Recruiting first, the newest first:
Hospital General Universitario Santa Lucia · Sites in Spain
Ages 18+
Fundación Interhospitalaria para la Investigación Cardiovascular FIC · Sites in Spain
Ages 18+
Hospital Universitario La Fe · Sites in Spain
Ages 18+
Hospital Arnau de Vilanova · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 124 ST Elevation Myocardial Infarction studies recruiting now, 78 (63%) set no upper age limit and 20 (16%) stop at 75 or younger; 10 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 6 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 250 is above the median of 194 across 531 interventional studies indexed under ST Elevation Myocardial Infarction.
Median enrollment 450 across the 27 interventional studies, 495 across the 14 observational. Of the 24 that completed or were terminated, 5 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 41 have an industry lead sponsor. The 10 most frequent:
Hospital General Universitario de Valencia is the lead sponsor of 11 studies on the registry; 3 are open to participants now.
Hospital General Universitario de Valencia has 1 study filed under ST Elevation Myocardial Infarction — fewer than ten, so there is no comparison to draw.
4 of the studies in ST Elevation Myocardial Infarction with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07102628Phase 3Novartis PharmaceuticalsEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes | 2027-01-16 |
| NCT07780942Hospital General Universitario Santa LuciaSMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest Pain | 2027-02 |
| NCT07000266Fundacio Privada Mon Clinic BarcelonaThe RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack | 2027-05-16 |
| NCT07444957Fundación Interhospitalaria para la Investigación Cardiovascular FICSafety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease | 2027-07-05 |
Add all 4 to your calendar (.ics) → With an account.
Among the 41 studies in ST Elevation Myocardial Infarction with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patients with STEMI and multivessel disease in whom the culprit lesion has been successfully revascularized during prmimary PCI, will be randomized to in-hospital or after-discharge complete revascularization.
The purpose of this study is to evaluate the impact of these two different strategies in terms of hospital stay.
STEMI patients with mutivessel disease are, after successful primary angioplasty, randomized 1:1 ratio to either in-hospital complete revascularization or after-discharge complete revascularization strategy.
Eligible non-culprit coronary arteries must be >2.0 mm in diameter and at the discretion of the operator suitable for PCI. Only arteries with angiographically stenoses ≥70% or between ≥50% and \<70 in proximal segments can be randomized.
Patients in the in-hospital revascularization group will undergo to non-culprit percutaneous coronary intervention (PCI) at least 24 hours after ST-segment elevation myocardial infarction. On the other hand, patients in the after-discharge group will undergo to non-culprit PCI within 4-6 weeks after STEMI.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will undergo to a complete revascularization of non-culprit lesions at least 24 hours after STEMI and before hospital discharge.
Other: In-hospital nonculprit-lesions percutaneous coronary intervention (PCI)
Patients will undergo to a complete revascularization of non-culprit lesions after hospital discharge within 4-6 weeks after STEMI.
Other: After-discharge nonculprit-lesions percutaneous coronary intervention (PCI)
To perform percutaneous coronary intervention of non-culprit vessels in a staged procedure during index admission.
To perform percutaneous coronary intervention of non-culprit vessels in a staged procedure after hospital discharge.
Impact in hospital stay
To evaluate the impact of two different revascularization strategies (in-hospital versus after-discharge) in terms of hospital stay (days) in patients with a STEMI and multivessel disease.
Time frame: 6 months
Cardiovascular death, acute myocardial infarction or revascularization.
Composite of cardiovascular death, myocardial infarction, or ischemia driven revascularization of non-culprit coronary lesions eligible for and randomized to either of the two strategies.
Time frame: 1 year
Fractional flow reserve of angiographically moderate stenosis
Evaluate the presence of ischemia by analyzing the fractional flow reserve of angiographically moderate stenoses (≥50% and \<70) in proximal segments of the anterior descending, circumflex, or right coronary artery.
Time frame: 6 months
Plan to share: No
Ran from Jan 2018 to primary completion in Nov 2021, 46 months.
Of 135 non-industry interventional studies with no phase under ST Elevation Myocardial Infarction, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 70. This study's 46 months is above that.
Counting every sponsor, half of 145 studies reached it within 40 months; a quarter within 19 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ST Elevation Myocardial Infarction →
Hospital General Universitario de Valencia